Ben Gil Price, Director at AVI BIOPHARMA INC (AVII), bought 50,400 shares at $0.67 ($33K) on 2009-03-16, disclosed to the SEC on 2009-03-17.
Open-market purchase of $33k AVII by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.65 | 30,000 | $20K | 58.8% |
| 2 | $0.67 | 20,400 | $14K | 41.2% |
| Total | $0.66 avg | 50,400 | $33K | 100% |
| Filing → |
| SRPT | BUY | 2013-08-20 | $16K | — | Filing → |
| AVII | BUY | 2012-03-15 | $39K | — | Filing → |
| AVII | BUY | 2011-04-06 | $30K | — | Filing → |